$1.99 +0.01 (%) Oculus Innovative Sciences Inc - NASDAQ

Oct. 21, 2014 | 09:57 AM

Partner Headlines

  1. Morning Market Losers

    Benzinga | Jun. 13, 2014 | 09:44AM EST
  2. Morning Market Movers

    Benzinga | Jun. 11, 2014 | 09:40AM EST
  3. Oculus Innovative Sciences Announces Received 'Strong Consensus' Rating for Use With Kinetic Concepts' Negative Pressure Wound Therapy With Instillation

    Benzinga | Apr. 9, 2014 | 08:11AM EST
  4. Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors

    Benzinga | Mar. 27, 2014 | 08:08AM EST
  5. Unrelated Oculus Firms Rally on Facebook Buy

    FoxBusiness | Mar. 26, 2014 | 11:25AM EST
  6. Oculus Receives Mexican Ministry of Health Approval of Microcyn(R)-Based Hydrogel for Management of Scars

    Benzinga | Dec. 12, 2013 | 08:08AM EST
  7. Oculus Innovative Sciences Announces 550K Share Offering at $4.00/Share

    Benzinga | Dec. 5, 2013 | 00:50AM EST
  8. Morning Market Movers

    Benzinga | Dec. 4, 2013 | 09:52AM EST
  9. Stocks Hitting 52-Week Lows

    Benzinga | Nov. 21, 2013 | 10:03AM EST
  10. Oculus' Ruthigen Establishes Independent HQ, Expecting IPO in 2013

    Benzinga | Jan. 28, 2013 | 01:13AM EST
  11. Benzinga's Small Cap Movers for Friday December 28, 2012

    Benzinga | Dec. 30, 2012 | 04:17AM EST
  12. Oculus Innovative Sciences Issued US Patent for Treatment of Skin Ulcers with Microcyn Technology

    Benzinga | Dec. 27, 2012 | 01:13AM EST
  13. Oculus Sees Expanded Label Claim for European Formulation of Dermacyn Wound Care

    Benzinga | Dec. 24, 2012 | 01:15AM EST
  14. Oculus Offers 2HCY12 Business Update

    Benzinga | Dec. 11, 2012 | 01:15AM EST
  15. Oculus Innovative Sciences Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 8, 2012 | 11:36AM EST
  16. Oculus Gets Patent For Use of Microcyn Technology

    Benzinga | Sep. 11, 2012 | 02:09AM EST
  17. Oculus Innovative Sciences Receives $5.1M Licensing Fee

    Benzinga | Sep. 6, 2012 | 02:13AM EST
  18. Oculus Innovative Sciences Enrolls First Patient in Study of Microcyn Hydrogel in Management of Scars

    Benzinga | Aug. 16, 2012 | 02:08AM EST
  19. Oculus Innovative Sciences Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 3, 2012 | 13:26PM EST
  20. Oculus Innovative Sciences Receives Chinese SFDA Regulatory Approval of Microcyn Hydrogel

    Benzinga | Jul. 10, 2012 | 02:18AM EST
  21. AmDerma and Oculus Innovative Sciences Enter Into Multi-Country Agreement to Develop and Commercialize Novel Microcyn-Based Drugs for Major Dermatological Conditions

    Benzinga | Jun. 25, 2012 | 02:10AM EST
  22. Earnings Scheduled For June 7

    Benzinga | Jun. 6, 2012 | 21:18PM EST
  23. Oculus Innovative Sciences Inc. Reports Operating Results (10-Q)

    GuruFocus | Feb. 10, 2012 | 11:37AM EST
  24. Oculus Innovative Sciences, Inc. to Raise Approximately $2.0 Million in Registered Direct Offering

    Benzinga | Dec. 23, 2011 | 01:08AM EST
Trading Center